Table 1. Patient characteristics.
| N | % | Mean | Range | |
| Patients | 25 | - | - | - |
| Age (years) | - | - | 58 | 31-74 |
| Sex | ||||
| Male | 18 | 72 | ||
| Female | 7 | 28 | - | - |
| Weight (kg) | - | - | 77 | 50.8-121 |
| Height (cm) | - | - | 167.6 | 153-182 |
| Body mass index (kg/m2) | - | - | 27.2 | 19.2-38.1 |
| ECOG | ||||
| 0 | 10 | 40 | - | - |
| 1 | 12 | 48 | - | - |
| 2 | 3 | 12 | - | - |
| Tumours | ||||
| NSCLC stage IV | 12 | 48 | - | - |
| SCLC | 2 | 8 | - | - |
| Bladder cancer | 5 | 20 | - | - |
| Pelvis kidney cancer | 1 | 4 | - | - |
| Tongue cancer | 1 | 4 | - | - |
| Nasopharynx cancer | 2 | 8 | - | - |
| Testicular cancer | 1 | 4 | - | - |
| Cancer of unknown origin | 1 | 4 | - | - |
| Platinum | ||||
| Cisplatin | 21 | 84 | - | - |
| Carboplatin | 4 | 16 | - | - |
| Dose of platinum (mg) | ||||
| Cisplatin | - | - | 131.5 | 48–165 |
| Carboplatin | - | - | 626.5 | 450–750 |